National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

probenecid
A benzoic acid derivative with antihyperuricemic property. Probenecid competitively inhibits the active reabsorption of urate at the proximal tubule in the kidney thereby increasing urinary excretion of uric acid and lowering serum urate concentrations. This prevents urate deposition and promotes resolution of existing urate deposits. In addition, probenecid modulates the transport of organic acids and acidic drugs at the proximal and distal renal tubule, thereby increasing the drug serum concentration. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

US brand names:Benemid
SK-Probenecid
Abbreviation:PROB



Previous:Prelone, Premarin, Prialt, Prilosec, prinomastat
Next:procarbazine hydrochloride, prochlorperazine, Procrit, Proctocort, Profasi

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov